CAM Herbs and Cardiovascular Health: Ginseng to St. John's Wort
This paper examines four complementary and alternative medicine (CAM) modalities—Ginseng, Hawthorn, L-Arginine, and St. John's Wort—and their impact on the cardiovascular system. For each herb or supplement, the paper reviews its known effects on cardiovascular functioning, anticipated therapeutic benefits, identified risks and adverse effects, and relevant patient education considerations. Drawing on peer-reviewed literature, the paper highlights how these CAM treatments address conditions such as hypertension, heart failure, dyslipidemia, and depression-related cardiac risk. It also underscores areas where further clinical research is needed to confirm long-term safety and efficacy.
- Introduction to CAM and Cardiovascular Health: Defines CAM and introduces four modalities reviewed
- Ginseng: Ginseng's cardiovascular effects, benefits, risks, and dosage
- Hawthorn: Hawthorn's role in heart failure and blood pressure management
- L-Arginine: L-Arginine as nitric oxide substrate for cardiovascular regulation
- St. John's Wort: St. John's Wort for depression and indirect cardiac effects
- Conclusion: Summary of CAM modalities and clinical implications
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper uses a consistent four-part structure for each CAM modality (cardiovascular effect, anticipated benefits, risks, and patient education), making it easy to compare treatments and locate specific clinical information.
- Citations are current and drawn from peer-reviewed pharmacology and cardiology journals, lending credibility to each claim and demonstrating appropriate use of evidence in a health sciences paper.
- The patient education sections translate technical findings into practical guidance (dosage ranges, dietary sources, interaction warnings), showing awareness of real-world clinical application.
Key academic technique demonstrated
The paper demonstrates systematic comparative analysis across multiple interventions using a parallel structure. By applying the same analytical framework to each supplement, the author allows readers to evaluate relative benefits and risks across CAM modalities without losing argumentative coherence. This technique is common in evidence-based health sciences writing where clinical decision-making depends on standardized assessment criteria.
Structure breakdown
The paper opens with a brief introduction defining CAM and scoping the four modalities under review. Each subsequent section is organized identically: cardiovascular system effects, anticipated benefits, identified risks or adverse effects, and patient education. This parallel structure spans four herb/supplement profiles before closing without a formal conclusion section. The reference list follows APA format throughout.
Introduction to CAM and Cardiovascular Health
The extensive use of Complementary and Alternative Medicine (CAM) has prompted healthcare professionals and governmental bodies to reconsider the strategies and policies that could inform healthcare reform. It is fundamentally important to understand what falls under the definition of CAM. In the United States, CAM is interpreted as an amalgamation of relaxation techniques, chiropractic care, herbal treatments, and massage therapy (Institute of Medicine (US) Committee on the Use of Complementary and Alternative Medicine by the American Public, 2005). This paper investigates the use of CAM healthcare modalities — specifically Ginseng, Hawthorn, L-Arginine, and St. John's Wort — and their impact on the cardiovascular system.
Ginseng
The cardiovascular system is adversely affected when diseases such as hypertension, dyslipidemia, peripheral vascular disease, and coronary artery disease are present, regardless of patient gender (Kim, 2012). The most common form of ginseng used in CAM-based cardiovascular care is Panax ginseng, which is considered beneficial in China, Japan, and Korea. Ginseng has proven effective in controlling hypertension and improving arterial functioning (Shaito et al., 2020). Other cardiovascular disease (CVD) management properties provided by ginseng include anti-oxidant and anti-hyperlipidemic attributes, as well as application in anti-diabetic therapy. The reduction of central and peripheral arterial pressures has been extensively studied using this herb (Shaito et al., 2020).
Ginseng possesses anti-inflammatory, anti-oxidant, and anti-cancer properties that are also valuable to the nervous system (Kim, 2012). In terms of cardiovascular impact, it is used for treating elevated blood pressure. It improves blood circulation to promote cardiovascular health through its anti-hypertensive effects (Kim, 2012). Moreover, it protects against heart tissue damage, particularly when the organ is under stress (Kim, 2012), and is therefore considered relatively safe in terms of side effects. Heart rate and cardiac functioning have been shown to improve, as ginseng inhibits cardiomyocyte hypertrophy through Nhe-1 inhibition and activation of calcineurin (Kim, 2012). Positive effects of ginseng on vascular endothelial cells have also been noted. Additionally, the production of nitric oxide (NO) to control vascular smooth muscle functioning has been attributed to ginseng (Kim, 2012).
Although evidence on the adverse effects of ginseng on cardiovascular health is limited, its long-term use or high dosage has been associated with hypertension in 17% of study participants and hypotension in 10% (Paik & Lee, 2015). These findings were particularly relevant to cardiovascular impact, alongside other negative health effects such as morning diarrhea, skin flare-ups, anxiety, wakefulness, edema, decreased appetite, and depression.
Cardiovascular patients should know that ginseng is typically taken as a whole dried root, an extract, a tea, or a capsule (Cardiology Review Online, 2004). Its active compounds are ginsenosides. The recommended dosage for positive cardiovascular impact is 100 to 400 mg of ginseng extract daily. For ginseng root, German Commission E recommends 1 to 2 g daily.
Hawthorn
Hawthorn has been effective in controlling blood pressure levels, a critical factor for cardiovascular health. Treatment with Hawthorn has also been noted for addressing hypotension, as it creates a lasting pressoric effect (Tassell et al., 2010). This herb has shown effectiveness in managing mild to moderate heart failure. Vaso-relaxation from nitrous stimulation and significant anti-oxidant activity have been observed to produce beneficial cardiovascular effects.
Its use alongside vasodilatory agents in medications has not been reported as adverse for cardiac functioning (Tassell et al., 2010). Its numerous advantageous properties — including anti-arrhythmic, hypotensive, and hypolipidemic effects on cardiovascular health — are still being investigated for long-term efficacy and potential in treating cardiac ailments (Chang, Dao & Shao, 2005). Hawthorn is also believed to be efficacious in treating patients with heart failure (Rabito & Kaye, 2013). Its performance in symptom control and physiological outcomes has been particularly impressive for chronic heart failure. Improvement in shortness of breath during exercise, better oxygen consumption, and reduced fatigue have all been reported. Research findings indicated that patients treated for cardiac problems using Hawthorn showed signs of improvement and fewer consequential cardiac deaths for left ejection fractions ranging between 25% and 35% (Rabito & Kaye, 2013).
A systematic review of existing literature on Hawthorn's adverse effects found that its mild cardiovascular-related effects can include circulation failure and palpitations (Daniele et al., 2006). Other adverse effects include migraine, headaches, gastric complaints, dizziness, nausea, and erythematous rash. Nonetheless, a more in-depth evaluation of effects relative to dosage is still needed so that clearer safety recommendations can be made.
Patients should be aware that the recommended daily usage of Hawthorn is 160 mg to 1,800 mg; however, this may be increased to achieve greater therapeutic effectiveness (Dahmer & Scott, 2010). A standardized extract form, as proposed by the treating physician, is advisable and may be taken two to three times daily. Patients should self-adhere to and self-monitor their dosage to guard against overdose. Four to eight weeks of use are generally suggested before positive cardiovascular results are observed.
Conclusion
The four CAM modalities examined — Ginseng, Hawthorn, L-Arginine, and St. John's Wort — each demonstrate meaningful, though varying, effects on the cardiovascular system. Ginseng and Hawthorn offer anti-hypertensive, anti-oxidant, and heart-failure management benefits, while L-Arginine supports nitric oxide-mediated blood pressure regulation. St. John's Wort addresses cardiovascular risk indirectly through its antidepressant effects. In each case, patient education regarding appropriate dosage, potential adverse effects, and drug interactions is essential. Continued clinical research is necessary to fully establish the long-term safety and efficacy of these treatments, particularly in vulnerable populations such as the elderly and those on multiple medications.
References
Albaugh, V. & Barbul, A. (2017). Arginine. In B. Roitberg (Ed.), Reference Module in Life Sciences. Elsevier. https://doi.org/10.1016/B978-0-12-809633-8.06082-9
American Heart Association. (2021, June 22). How does depression affect the heart? https://www.heart.org/en/healthy-living/healthy-lifestyle/mental-health-and-wellbeing/how-does-depression-affect-the-heart
Bahadoran, Z., Mirmiran, P., Tahmasebinejad, Z., & Azizi, F. (2016). Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose study. Nutrition & Metabolism, 13, 23. https://doi.org/10.1186/s12986-016-0084-z
Bonaterra, G. A., Mierau, O., Hofmann, J., Schwarzbach, H., Aziz-Kalbhenn, H., Kolb, C., & Kinscherf, R. (2020). In vitro effects of St. John's Wort extract against inflammatory and oxidative stress and on the phagocytic and migratory activity of mouse SIM-A9 microglia. Frontiers in Pharmacology, 11.
Cardiology Review Online. (2004). Cardiovascular benefits and adverse effects of common herbal therapies. Cardiology Review Online, 21(6). Available at HCP Live.
Chang, W., Dao, J., & Shao, Z. (2005). Hawthorn: Potential roles in cardiovascular disease. The American Journal of Chinese Medicine, 33(1), 1–10.
Cohen, P. A. & Ernst, E. (2010). Safety of herbal supplements: A guide for cardiologists. Cardiovascular Therapeutics, 28(4), 246–253.
Cziráki, A., Lenkey, Z., Sulyok, E., Szokodi, I., & Koller, A. (2020). L-Arginine–nitric oxide–asymmetric dimethylarginine pathway and the coronary circulation: Translation of basic science results to clinical practice. Frontiers in Pharmacology, 11, 569914.
Dahmer, S. & Scott, E. (2010). Health effects of Hawthorn. American Family Physician, 81(4), 465–468.
Daniele, C., Mazzanti, G., Pittler, M. H., & Ernst, E. (2006). Adverse-event profile of Crataegus spp.: A systematic review. Drug Safety, 29(6), 523–535. https://doi.org/10.2165/00002018-200629060-00005
Dong, J., Qin, L., Zhang, Z., Zhao, Y., Wang, J., Arigoni, F., & Zhang, W. (2011). Effect of oral L-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials. American Heart Journal, 162(6), 959–965. https://doi.org/10.1016/j.ahj.2011.09.012
Eggertsen, R., Andreasson, A., & Andren, L. (2007). Effects of treatment with a commercially available St. John's Wort product (Movina) on cholesterol levels in patients with hypercholesterolemia treated with simvastatin. Scandinavian Journal of Primary Health Care, 25(3), 154–159.
Fisher, K. A., Patel, P., Abualula, S., & Concepcion, L. (2021). St. John's Wort-induced supraventricular tachycardia. Cureus, 13(4), e14356. https://doi.org/10.7759/cureus.14356
Institute of Medicine (US) Committee on the Use of Complementary and Alternative Medicine by the American Public. (2005). Complementary and alternative medicine in the United States. National Academies Press. Available from: https://www.ncbi.nlm.nih.gov/books/NBK83804/
Kim, J. H. (2012). Cardiovascular diseases and Panax ginseng: A review on molecular mechanisms and medical applications. Journal of Ginseng Research, 36(1), 16–26.
Li, H., Liu, Q., Zou, Z., Chen, Q., Wang, W., Baccarelli, A. A., Deng, F., Guo, X., & Wu, S. (2021). L-arginine supplementation to mitigate cardiovascular effects of walking outside in the context of traffic-related air pollution in participants with elevated blood pressure: A randomized, double-blind, placebo-controlled trial. Environment International, 156. https://doi.org/10.1016/j.envint.2021.106631
Maidment, I. (2000). The use of St. John's Wort in the treatment of depression. Psychiatric Bulletin, 24(6), 232–234. https://doi.org/10.1192/pb.24.6.232
Paik, D. J. & Lee, C. H. (2015). Review of cases of patient risk associated with ginseng abuse and misuse. Journal of Ginseng Research, 39(2), 89–93. https://doi.org/10.1016/j.jgr.2014.11.005
Rabito, M. J. & Kaye, A. D. (2013). Complementary and alternative medicine and cardiovascular disease: An evidence-based review. Evidence-Based Complementary and Alternative Medicine, 2013.
Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., Hare, J. M., & Gerstenblith, G. (2006). L-arginine therapy in acute myocardial infarction: The Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA, 295(1), 58–64.
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G., Eid, A. H., & Pintus, G. (2020). Herbal medicine for cardiovascular diseases: Efficacy, mechanism, and safety. Frontiers in Pharmacology, 11.
Tassell, M. C., Kingston, R., Gilroy, D., Lehane, M., & Furey, A. (2010). Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease. Pharmacognosy Reviews, 4(7), 32–41. https://doi.org/10.4103/0973-7847.65324
Always verify citation format against your institution’s current style guide requirements.